BDA advises Chemfield Cellulose on divestment to Oji Holdings

BDA Partners is pleased to announce that it has successfully advised its clients, Chemfield Cellulose Pvt Ltd and its shareholders, on the divestment of a strategic stake to Oji Holdings.

Chemfield is a leading Indian developer and manufacturer of MCC (microcrystalline cellulose) excipients and its derivatives. Microcrystalline cellulose is a refined, high-purity cellulose powder that serves as a critical excipient in pharmaceutical formulations. It is also widely used in dietary supplements and food applications.

BDA acted as exclusive financial advisor to Chemfield and its shareholders on the transaction.

Chemfield has been an Indian pioneer in spray-dried MCC. Chemfield is a research-driven, high-quality MCC manufacturer. The company developed expertise in complex-to-manufacture products, with capabilities in high-density and low-moisture variants of MCC. Chemfield has established a strong market presence by offering a highly competitive product portfolio to meet stringent quality standards, especially the elimination of carcinogenic nitrosamines.

Going forward, Oji aims to expand in the high-value-added sector, building an integrated production and sales system for pulp-derived products, such as MCC, as a downstream extension of its existing pulp raw material business. Through this initiative, Oji will develop its wood-based bio-business, leveraging forest resources to create sustainable value.

Aneesh Taneja, Director, Chemfield, said “We’re excited about the strategic investment in Chemfield by Oji. We look forward to leveraging Oji’s scale and expertise to drive future growth for Chemfield. The BDA team played a pivotal role in this transaction, using its sector expertise and global investor access to find the optimal strategic partner for Chemfield in our next phase of growth.”

Sanjay Singh, Head of India and Co-Head Healthcare, Asia at BDA Partners, said “We’re pleased to have helped Chemfield to find the ideal partner. Oji’s strategic capabilities and scale will be instrumental in accelerating Chemfield’s growth. We extend our best wishes to both the Chemfield and Oji teams as they embark on this new journey together. This deal reinforces our reputation as the advisor of choice for cross-border M&A and PE transactions.”